COVID won't get us anywhere close to three figures. My guess is something in the 20's with approval, although the hype could push past that before drawing back.

Success in the basket cancer trial is beyond calculation. We would need to find out the number of patients expressing CCR5 to get a better handle on it, but it would be safe to let your imagination run wild if that becomes a reality.